-
Gujarat hospitals to join WHO’s ‘Solidarity’ clinical trial
expresspharma
May 05, 2020
The trial, to be conducted by the Indian Council of Medical Research (ICMR), at hospitals in Ahmedabad, Vadodara, Surat and Rajkot, will compare the effectiveness of four drugs against COVID-19.
-
NICE joins international collaboratives to respond to COVID-19
europeanpharmaceuticalreview
May 05, 2020
NICE in the UK has announced it will partner with international collaborations to share its work on COVID-19 and develop guidelines for healthcare professionals.
-
CDSCO extends WHO-GMP/CoPP validity by six months
expresspharma
May 04, 2020
The validities of WHO GMP/CoPP expiring between March to August 2020 will be extended by six months from the date of expiry of the certificate as per WHO GMP certification guidelines.
-
WHO calls for pharma to rapidly distribute malaria prevention and treatment tools
europeanpharmaceuticalreview
April 30, 2020
In light of the COVID-19 pandemic, WHO has asked the pharmaceutical supply chain to swiftly distribute nets and antimalarial medicines in sub-Saharan Africa.
-
How Fette Compacting China supports the Battle against COVID-19
PhamraSources.com
April 30, 2020
The global pandemic of COVID-19 has changed the focus towards epidemic prevention and control of the infection in all areas of the world.
-
WHO prematurely publishes remdesivir results
pharmatimes
April 24, 2020
The World Health Organisation has accidentally leaked disappointing data from a trial of Gilead's coronavirus hopeful remdesivir in China.
-
AJ Vaccines secures WHO Prequalification for polio vaccine Picovax
pharmaceutical-technology
April 23, 2020
Vaccine manufacturer AJ Vaccines has secured the World Health Organization (WHO) prequalification for a new polio vaccine called Picovax.
-
WHO publishes R&D roadmap for coronavirus Covid-19
pharmaceutical-technology
March 11, 2020
The World Health Organization (WHO) has published research and development (R&D) roadmap to address coronavirus Covid-19.
-
WHO chief calls for solidarity in fighting epidemics
Xinhuanet
February 17, 2020
The World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus on Saturday called for solidarity in fighting the epidemics here at the 56th Munich Security Conference (MSC).
-
WHO announces first biosimilar medicine pre-qualification
europeanpharmaceuticalreview
January 03, 2020
A trastuzumab biosimilar has been pre-qualified by WHO, marking its first, to improve access to the breast cancer treatment.